Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

Wall Street Unfazed by Trump’s 200% Pharma Tariffs Due to Extended Grace Period

by Team Lumida
July 14, 2025
in Macro
Reading Time: 4 mins read
A A
0
Trump Announces 25% Tariffs on Mexico and Canada, Targeting Border Security and Trade

"Donald Trump" by Gage Skidmore is licensed under CC BY-SA 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  1. Tariff Threat: President Trump has threatened a 200% tariff on imported pharmaceuticals, aiming to incentivize domestic manufacturing.
  2. Market Reaction: Despite the high tariff rate, Wall Street has reacted cautiously, with the NYSE Arca Pharmaceutical Index showing a slight increase, outperforming the S&P 500.
  3. Grace Period: The market’s calm response is largely due to Trump’s proposed “grace period” of about a year to a year and a half, which could extend tariff-free imports until 2027, with stockpiling potentially pushing it to 2028.
  4. Industry Response: Pharmaceutical companies are already stockpiling drugs and announcing major investments in U.S. manufacturing (e.g., Eli Lilly’s $27 billion plan), indicating the threat is working as intended.
  5. Tax Incentives: Trump’s “Big Beautiful Bill” offers tax relief, including immediate deductions for R&D and equipment purchases, and increased interest write-offs, making domestic production more financially viable.

What Happened?

President Trump announced a potential 200% tariff on imported pharmaceuticals, but simultaneously offered a grace period of 12 to 18 months. This grace period has significantly tempered Wall Street’s reaction, as it provides pharmaceutical companies ample time to adjust their supply chains.

In response to the tariff threat, the industry has already begun stockpiling drugs and making substantial investments in U.S. manufacturing facilities. Additionally, new tax incentives under Trump’s “Big Beautiful Bill” are designed to offset the costs of domestic production, making the shift more attractive.


Why It Matters?

This situation highlights a strategic approach to trade policy, where the threat of tariffs, combined with a grace period and tax incentives, is effectively driving reshoring of manufacturing without immediately imposing punitive costs. For the pharmaceutical industry, it means a significant shift in supply chain strategy, with a greater emphasis on domestic production for the U.S. market.

For investors, the extended timeline and supportive tax environment suggest that the financial impact of these tariffs on pharmaceutical companies may be minimal, allowing them to adapt and potentially even benefit from the new landscape.


What’s Next?

The pharmaceutical industry will continue to accelerate its efforts to build U.S. manufacturing capacity and stockpile drugs during the grace period. This could lead to a significant transformation of the U.S. pharmaceutical supply chain by the end of Trump’s term.

The success of this policy could serve as a model for other industries, demonstrating how a combination of threats and incentives can drive desired economic outcomes.

Source
Previous Post

AI Robot Massages Enter the Spa Scene, Challenging Traditional Therapists

Next Post

Meta to Build Gigawatt-Scale Data Centers for AI Superintelligence, Pentagon Awards AI Contracts

Recommended For You

Fed’s Waller Says the Fed May Need to ‘Shock People’ With a Half-Point Hike in December, Sending the 2-Year Treasury Yield Up More Than 4 Basis Points to 4.83%

by Team Lumida
14 hours ago

Waller said a 50 basis point hike is probably needed at the Dec. 8-9 meeting, and the 2-year Treasury yield jumped more than 4 basis points to 4.83%.

Read more

Treasuries Gain for a Third Day as the 10-Year Yield Slips 3 Basis Points to 5.08%, With Traders Saying Much of the Fed’s Coming Rate Hikes Is Already Priced In

by Team Lumida
22 hours ago

US Treasuries edged higher for a third day, with the 10-year yield down 3 basis points to 5.08% and the 2-year at 4.78%, as hike expectations look priced...

Read more

Iran Says It Struck U.S. Drone and Missile Sites in Kuwait as Gulf Attacks Mount, Yet WTI Settles Down 1.2% at $84.90 and Brent Slips to $92.70 on Recovering Hormuz Flows

by Team Lumida
22 hours ago

Iran claimed strikes on U.S. sites in Kuwait as the war enters its ninth month, but crude settled lower on signs of recovering Hormuz flows.

Read more

Trump, Xi and Putin Converge on Shenzhen for APEC With a Trade Truce Expiring in January 2027, $30 Billion of Promised Tariff Cuts Unscheduled and Nvidia’s China Chip Scandal in the Background

by Team Lumida
22 hours ago

Trump and Xi are expected to meet in Shenzhen this week to implement their trade deal, with Nvidia chips, tariffs and the Iran war all in play.

Read more

The 10-Year Treasury Yield Is Nearing Its Longest Stretch Above 5% Since 2007, With 27 Closes Above the Level in 2026 and a December Hike 95% Priced

by Team Lumida
2 days ago
KKR Lifts Its 10-Year Treasury Call to 5.1% and Pushes the Fed Hold Out to Early 2029

The 10-year yield, near 5.13%, is nearing its longest run above 5% since 2007, with 27 closes above that level so far in 2026.

Read more

Lisa Cook’s Lawyer Signals She Will Skip Trump’s Dec. 14 ‘Committee of Inquiry’ Hearing, Calling It a ‘Façade’ for a Predetermined Firing

by Team Lumida
2 days ago

Fed Governor Lisa Cook’s lawyer signaled she will not attend the White House committee hearing, calling the process a predetermined effort to fire her.

Read more

St. Louis Fed’s Musalem Says the Fed May Need Up to Four More Hikes by Spring 2027, as Retail Sales Ex-Autos and Gas Beat and the 10-Year Yield Rises to 5.145%

by Team Lumida
2 days ago

Musalem said the Fed may need several hikes before spring 2027 as core retail sales beat and the 10-year Treasury yield climbed to 5.145%.

Read more

Gold Futures Post Their Lowest Close Since October 2025 at $3,847.40 as the Dollar Hits New 52-Week Highs and BofA Says the Fed Is ‘Further Behind the Curve’

by Team Lumida
2 days ago
Gold Falls 0.6% to $4,356 on Rising Treasury Yields; Silver Down 1.1% on Rate Headwinds vs Industrial Demand; Copper Up 0.5% on Supply Concerns, Tech Rally

Gold futures fell 0.8% to their lowest close since October 2025 as the dollar hit new highs, while Treasury yields eased on risk aversion and cheaper oil.

Read more

Oil Edges Lower to $85 WTI Even as a Tanker Is Struck in Hormuz and a Third US Carrier Arrives, With Traders Betting on a Q4 Supply Surplus

by Team Lumida
2 days ago

Oil slipped Tuesday despite Iran’s escalating threats and a tanker strike in the Strait of Hormuz, as expectations of a global surplus weighed on prices.

Read more

Warsh Floats an AI ‘China Shock’ for Services at His Fed Task Force Meeting, Asking Whether to Expect Medium-Term Disinflation

by Team Lumida
2 days ago

Fed Chair Kevin Warsh’s AI task force weighed whether AI could cut service prices and jobs, a question that could eventually shape interest-rate policy.

Read more
Next Post
a black square with a blue logo on it

Meta to Build Gigawatt-Scale Data Centers for AI Superintelligence, Pentagon Awards AI Contracts

Trump Threatens New Wave of Tariffs, Targeting Key Trading Partners with Rates Up to 40%

Trump Threatens 100% Tariffs on Russia, Pledges NATO-Funded Arms for Ukraine

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Senate Confirms Kevin Warsh as Fed Chair in Closest Vote Ever

Trump Has Been Calling Warsh Repeatedly Since He Became Fed Chair — Seeking Counsel on Iran War and AI’s Economic Impact

August 6, 2026
a close up of a pile of coins

Bitcoin Funding Rates Turn Negative for First Time in 2025, Signaling Potential Local Bottom

January 10, 2025
Fed Official Warns of Inflation Risks Under Trump Presidency

Trump Threatens 25% Tariffs on EU Goods, Raising Fears of a Transatlantic Trade War

February 27, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018